These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
508 related items for PubMed ID: 8669846
21. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group. Valone FH, Friedman MA, Wittlinger PS, Drakes T, Eisenberg PD, Malec M, Hannigan JF, Brown BW. J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272 [Abstract] [Full Text] [Related]
22. Investigation into the usefulness and adverse events of CDDP, 5-fU and dl-leucovorin (PFL-therapy) for advanced colorectal cancer. Okabe S, Ishikawa T, Tanami H, Kuwabara H, Fukahara T, Udagawa M, Ootsukasa S, Arai T, Maruyama S, Murase N, Yamashita H, Iwai T. J Med Dent Sci; 2002 Jun; 49(2):77-84. PubMed ID: 12627817 [Abstract] [Full Text] [Related]
23. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK. J Clin Oncol; 1989 Oct; 7(10):1407-18. PubMed ID: 2476530 [Abstract] [Full Text] [Related]
24. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1. Jäger E, Heike M, Bernhard H, Klein O, Bernhard G, Lautz D, Michaelis J, Meyer zum Büschenfelde KH, Knuth A. J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717 [Abstract] [Full Text] [Related]
25. Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers. Sobrero A, Zaniboni A, Frassineti GL, Aschele C, Guglielmi A, Giuliani R, Ravaioli A, Lanfranco C, Caroti C, Arnoldi E, Barni S, Gallo L, Pessi MA, Turci D, Cortesi E, Grossi F, Frontini L, Piazza E, Bruzzi P, Labianca R. Ann Oncol; 2000 Nov; 11(11):1413-20. PubMed ID: 11142481 [Abstract] [Full Text] [Related]
26. Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. J Clin Oncol; 1989 Oct; 7(10):1437-46. PubMed ID: 2674332 [Abstract] [Full Text] [Related]
27. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin. Hennig IM, Naik JD, Brown S, Szubert A, Anthoney DA, Jackson DP, Melcher AM, Crawford SM, Bradley C, Brown JM, Seymour MT. J Clin Oncol; 2008 Jul 10; 26(20):3411-7. PubMed ID: 18612156 [Abstract] [Full Text] [Related]
28. Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group. Comella P, Crucitta E, De Vita F, De Lucia L, Farris A, Del Gaizo F, Palmeri S, Lannelli A, Mancarella S, Tafuto S, Maiorino L, Buzzi F, De Cataldis G, Associated Institutions of the Southern Italy Cooperative Oncology Group. Ann Oncol; 2002 Jun 10; 13(6):866-73. PubMed ID: 12123331 [Abstract] [Full Text] [Related]
29. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients. Guglielmi A, Aschele C, Grossi F, Tixi L, Sobrero A. Cytotechnology; 1996 Jun 10; 19(3):215-9. PubMed ID: 8862009 [Abstract] [Full Text] [Related]
30. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. Petrelli N, Herrera L, Rustum Y, Burke P, Creaven P, Stulc J, Emrich LJ, Mittelman A. J Clin Oncol; 1987 Oct 10; 5(10):1559-65. PubMed ID: 2443619 [Abstract] [Full Text] [Related]
31. FOLFOX as adjuvant chemotherapy after curative resection of distant metastases in patients with colorectal cancer. Nozawa H, Kitayama J, Sunami E, Saito S, Kanazawa T, Kazama S, Yazawa K, Kawai K, Mori K, Nagawa H. Oncology; 2011 Oct 10; 80(1-2):84-91. PubMed ID: 21677451 [Abstract] [Full Text] [Related]
32. Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Glimelius B. Ann Oncol; 1993 Mar 10; 4(3):235-40. PubMed ID: 8471555 [Abstract] [Full Text] [Related]
33. Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: a GISCAD study. Zaniboni A, Labianca R, Martignoni G, Barni S, Vinci M, Vaghi M, Pirovano M, Facendola G, Marini G, Luporini G. J Chemother; 1996 Feb 10; 8(1):82-4. PubMed ID: 8835115 [Abstract] [Full Text] [Related]
34. The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer. Marsh JC, Bertino JR, Katz KH, Davis CA, Durivage HJ, Rome LS, Richards F, Capizzi RL, Farber LR, Pasquale DN. J Clin Oncol; 1991 Mar 10; 9(3):371-80. PubMed ID: 1999706 [Abstract] [Full Text] [Related]
35. Multicenter phase II study of CPT-11 fractionated over two days with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer. Recchia F, Nuzzo A, Lalli A, Di Lullo L, De Filippis S, Saggio G, Di Blasio A, Rea S. Anticancer Res; 2003 Mar 10; 23(3C):2903-8. PubMed ID: 12926132 [Abstract] [Full Text] [Related]
36. Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer--a phase II study. Tomlinson SK, Melin SA, Higgs V, White DR, Savage P, Case D, Blackstock AW. BMC Cancer; 2002 May 02; 2():9. PubMed ID: 11988109 [Abstract] [Full Text] [Related]
37. A phase II trial of carboplatin, methotrexate and fluorouracil in fluorouracil-pretreated colorectal cancer. Pronzato P, Botto F, Ghio E, Pensa F, Tognoni A, Vaira F, Vigani A, Neri E. J Chemother; 1998 Jun 02; 10(3):254-7. PubMed ID: 9669653 [Abstract] [Full Text] [Related]
38. Double modulation of 5-fluorouracil by methotrexate and high-dose L-leucovorin in advanced colorectal cancer. Romero AO, Perez JE, Cuevas MA, Lacava JA, Sabatini CL, Dominguez ME, Rodriguez R, Barbieri MR, Ortiz EH, Salvadori MA, Acuña LA, Acuña JM, Langhi MJ, Amato S, Machiavelli MR, Leone BA, Vallejo CT, Lorusso V, DeLena M. Am J Clin Oncol; 1998 Feb 02; 21(1):94-8. PubMed ID: 9499269 [Abstract] [Full Text] [Related]
39. Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial. Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD). Aranda E, Cervantes A, Carrato A, Fernández-Martos C, Antón-Torres A, Massutí T, Barneto I, García-Conde J, Barón JM, Díaz-Rubio E. Ann Oncol; 1996 Aug 02; 7(6):581-5. PubMed ID: 8879371 [Abstract] [Full Text] [Related]
40. Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer. Goldberg RM, Hatfield AK, Kahn M, Sargent DJ, Knost JA, O'Connell MJ, Krook JE, Maillard JA, Wiesenfeld M, Schaefer PL, Tirona MT, Moertel CG. J Clin Oncol; 1997 Nov 02; 15(11):3320-9. PubMed ID: 9363861 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]